Paloma Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,402
| Closed | -$239K | – | 280 |
|
|
2024
Q3 | $239K | Buy |
+3,402
| New | +$239K | 0.01% | 640 |
|
|
2024
Q2 | – | Sell |
-421
| Closed | -$36.8K | – | 821 |
|
|
2024
Q1 | $36.8K | Buy |
421
+157
| +59% | +$13.7K | ﹤0.01% | 456 |
|
|
2023
Q4 | $25.5K | Sell |
264
-1,570
| -86% | -$151K | ﹤0.01% | 245 |
|
|
2023
Q3 | $162K | Buy |
+1,834
| New | +$162K | 0.01% | 157 |
|
|
2023
Q1 | – | Sell |
-2,550
| Closed | -$264K | – | 232 |
|
|
2022
Q4 | $264K | Hold |
2,550
| – | – | 0.01% | 207 |
|
|
2022
Q3 | $216K | Sell |
2,550
-8,075
| -76% | -$684K | 0.01% | 229 |
|
|
2022
Q2 | $881K | Buy |
10,625
+6,655
| +168% | +$552K | 0.03% | 271 |
|
|
2022
Q1 | $306K | Buy |
+3,970
| New | +$306K | 0.01% | 826 |
|
|
2021
Q3 | – | Sell |
-11,727
| Closed | -$979K | – | 943 |
|
|
2021
Q2 | $979K | Sell |
11,727
-3,258
| -22% | -$272K | 0.02% | 464 |
|
|
2021
Q1 | $1.13M | Buy |
14,985
+7,707
| +106% | +$582K | 0.02% | 490 |
|
|
2020
Q4 | $639K | Sell |
7,278
-27,179
| -79% | -$2.39M | 0.02% | 596 |
|
|
2020
Q3 | $2.62M | Buy |
34,457
+32,157
| +1,398% | +$2.45M | 0.07% | 240 |
|
|
2020
Q2 | $284K | Sell |
2,300
-3,100
| -57% | -$383K | ﹤0.01% | 1352 |
|
|
2020
Q1 | $456K | Buy |
5,400
+1,817
| +51% | +$153K | 0.03% | 460 |
|
|
2019
Q4 | $303K | Sell |
3,583
-21,716
| -86% | -$1.84M | ﹤0.01% | 1458 |
|
|
2019
Q3 | $1.71M | Buy |
25,299
+21,555
| +576% | +$1.45M | 0.04% | 365 |
|
|
2019
Q2 | $320K | Sell |
3,744
-17,485
| -82% | -$1.49M | 0.01% | 1030 |
|
|
2019
Q1 | $1.89M | Buy |
21,229
+18,270
| +617% | +$1.62M | 0.05% | 323 |
|
|
2018
Q4 | $253K | Sell |
2,959
-4,397
| -60% | -$376K | 0.01% | 702 |
|
|
2018
Q3 | $713K | Buy |
7,356
+2,431
| +49% | +$236K | 0.01% | 643 |
|
|
2018
Q2 | $464K | Sell |
4,925
-5,513
| -53% | -$519K | 0.01% | 782 |
|
|
2018
Q1 | $847K | Buy |
10,438
+2,636
| +34% | +$214K | 0.01% | 665 |
|
|
2017
Q4 | $696K | Sell |
7,802
-301
| -4% | -$26.9K | 0.01% | 672 |
|
|
2017
Q3 | $754K | Sell |
8,103
-14,315
| -64% | -$1.33M | 0.01% | 783 |
|
|
2017
Q2 | $2.04M | Buy |
22,418
+6,302
| +39% | +$572K | 0.02% | 411 |
|
|
2017
Q1 | $1.42M | Sell |
16,116
-12,730
| -44% | -$1.12M | 0.02% | 631 |
|
|
2016
Q4 | $2.39M | Buy |
28,846
+6,251
| +28% | +$518K | 0.02% | 335 |
|
|
2016
Q3 | $2.09M | Buy |
22,595
+1,771
| +9% | +$164K | 0.03% | 261 |
|
|
2016
Q2 | $1.62M | Buy |
20,824
+17,290
| +489% | +$1.35M | 0.02% | 557 |
|
|
2016
Q1 | $292K | Buy |
+3,534
| New | +$292K | ﹤0.01% | 1151 |
|
|
2015
Q4 | – | Sell |
-10,009
| Closed | -$1.05M | – | 1368 |
|
|
2015
Q3 | $1.05M | Sell |
10,009
-92,591
| -90% | -$9.75M | 0.02% | 408 |
|
|
2015
Q2 | $14M | Buy |
102,600
+94,904
| +1,233% | +$13M | 0.27% | 28 |
|
|
2015
Q1 | $959K | Sell |
7,696
-3,691
| -32% | -$460K | 0.03% | 422 |
|
|
2014
Q4 | $1.03M | Sell |
11,387
-12,039
| -51% | -$1.09M | 0.04% | 346 |
|
|
2014
Q3 | $1.69M | Sell |
23,426
-11,677
| -33% | -$842K | 0.08% | 227 |
|
|
2014
Q2 | $2.18M | Buy |
+35,103
| New | +$2.18M | 0.09% | 179 |
|